Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Rituximab of obinutuzumab of plus CHOP bij nieuw-gediagnostiseerd DLBCL
aug 2017 | Lymfoom